Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Do physicians in primary health care recognize pulmonary fibrosis?

Minna Purokivi, Marjukka Myllärniemi, Ulla Hodgson, Eija-Riitta Salomaa, Riitta Kaarteenaho
European Respiratory Journal 2015 46: PA2045; DOI: 10.1183/13993003.congress-2015.PA2045
Minna Purokivi
1Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjukka Myllärniemi
2Department of Clinical Medicine and Transplantation Laboratory, University of Helsinki, Helsinki, Finland
3Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulla Hodgson
2Department of Clinical Medicine and Transplantation Laboratory, University of Helsinki, Helsinki, Finland
3Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eija-Riitta Salomaa
4Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riitta Kaarteenaho
1Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland
5Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland
6Respiratory Research Unit and Clinical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

The early diagnosis of idiopathic pulmonary fibrosis (IPF) is important due to improved treatment options. We have evaluated the quality of referral letters sent to tertiary care by primary health care physicians in relation to the recognition of IPF.

Ninety-five referral letters of patients with IPF identified from a subcohort of patients in the FinnishIPF study were evaluated with respect to time of referral, referring unit, grounds for referral, symptoms, smoking status, occupational history, clinical examinations, co-morbidities, medication, radiological findings and lung function. The overall quality of the referral letter was also estimated.

Fifty-nine percent of referral letters had originated from public health care. The quality of 53 % of the referral letters was estimated as either good or excellent. The time from symptom onset to referral was reported in 60% of cases, being 1.5 years on average. The main reason for referral was the suspicion of parenchymal lung disease (63%). Alterations in chest X-ray were listed as one reason for referring in 53% of cases. Cough (43%) and dyspnea (46%) were the most common symptoms. Inspiratory crackles in lung auscultation were reported in 52% of cases. Shortcomings in referral letters were estimated to have led to significant delays for eight (9%) subjects.

IPF can be detected in primary health care based on symptoms as well as clinical and radiological examinations. Education, however, would improve recognition of IPF among primary health care physicians. Informing the general public of parenchymal lung diseases might also shorten the delay from symptom onset to seeking help from health care professionals.

  • Idiopathic pulmonary fibrosis
  • Orphan disease
  • Primary care
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Do physicians in primary health care recognize pulmonary fibrosis?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Do physicians in primary health care recognize pulmonary fibrosis?
Minna Purokivi, Marjukka Myllärniemi, Ulla Hodgson, Eija-Riitta Salomaa, Riitta Kaarteenaho
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2045; DOI: 10.1183/13993003.congress-2015.PA2045

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Do physicians in primary health care recognize pulmonary fibrosis?
Minna Purokivi, Marjukka Myllärniemi, Ulla Hodgson, Eija-Riitta Salomaa, Riitta Kaarteenaho
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2045; DOI: 10.1183/13993003.congress-2015.PA2045
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society